A Study to Characterize the PK and PD Profile of IV FCM in Pediatric Subjects 1-17 Years Old With IDA

NCT02410213 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

35

Enrollment

INDUSTRY

Sponsor class

Conditions

Iron Deficiency Anemia (IDA)

Interventions

DRUG: Ferric Carboxymaltose (FCM)

Sponsor

American Regent, Inc.